Gansan, Benjamin G.

HRN: 20-11-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
CEFUROXIME 1.5GM (VIAL)
07/30/2026
08/05/2026
IV
1.5G
Q8
Lacerated Wound Occipital Area
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: